Kevin Hart’s VC firm leads $35M Series B for weight-loss app Simple

Simple, an AI-powered health coaching app, has closed a $35 million Series B funding round led by Kevin Hart’s Hartbeat Ventures, bringing its total funding to $45 million. The company reports $160 million in annual recurring revenue (ARR) and 700,000 subscribers for its platform, which utilizes an AI coach, Avo, and large language models (LLMs) to provide personalized weight management advice and real-time feedback. Simple differentiates itself from competitors like Noom by focusing on tailored coaching and complementing GLP-1 users, with plans to expand into women's health and midlife programs, aiming to become a comprehensive health companion beyond weight loss.

Analysis

Simple, an AI-powered health coaching application, has secured a $35 million Series B funding round, bringing its total capital raised to $45 million. The investment is underpinned by substantial commercial traction, as the company reports $160 million in annual recurring revenue (ARR) from 700,000 subscribers and claims to be profitable. Its core offering is an AI coach, Avo, which leverages large language models to deliver personalized plans and feedback, a feature that distinguishes it from competitors like Noom and Weightwatchers by focusing on tailored coaching over generic tracking. Strategically, Simple is positioning itself as a complementary "behaviour engine" for the rapidly growing GLP-1 medication market, aiming to support user habits without directly supplying the drugs. The new capital, led by Hartbeat Ventures, is intended to fund expansion into specialized programs for women's health and midlife, with a long-term vision to evolve into a comprehensive health companion for sleep, stress, and movement, explicitly aspiring to become the "Duolingo of health."

Key Decisions for Investors

• Investors in competitors like Noom and WW International should recognize Simple's $160M ARR as proof of a significant competitive threat from AI-native platforms, necessitating a re-evaluation of incumbents' technological moats.
• The strategy to serve as a 'behaviour engine' for the GLP-1 market highlights a lucrative, lower-risk approach to the obesity drug trend; investors should identify other companies providing ancillary services to this growing user base.
• Simple's high capital efficiency and explicit comparison to Duolingo (DUOL) provides a valuation and strategic benchmark for assessing other private and public companies applying AI-driven, subscription-based models to consumer wellness.